Bristol Gate Capital Partners »

Eli Lilly & Co. shares owned by Bristol Gate Capital Partners

Quarter-by-quarter ownership of Eli Lilly & Co. (LLY) shares owned by Bristol Gate Capital Partners from 13F filings

Historical chart of Bristol Gate Capital Partners investment in Eli Lilly & Co.

Tip: Access up to 7 years of quarterly data

All positions including Eli Lilly & Co. held by Bristol Gate Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eli Lilly & Co. by Bristol Gate Capital Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $72M 94k 763.00
2025-06-30 $76M 97k 779.53
2025-03-31 $98M 118k 825.91

More positions owned by Bristol Gate Capital Partners

Broadcom (AVGO)
Ge Aerospace Com New (GE)
Microsoft Corporation (MSFT)
UnitedHealth (UNH)
Mastercard Incorporated Cl A (MA)
Applied Materials (AMAT)
Visa Com Cl A (V)
Thermo Fisher Scientific (TMO)
Sherwin-Williams Company (SHW)
McKesson Corporation (MCK)
Cintas Corporation (CTAS)
Wabtec Corporation (WAB)
Intuit (INTU)
Moody's Corporation (MCO)
Eli Lilly & Co. (LLY)

View all positions for Bristol Gate Capital Partners

Top funds holding Eli Lilly & Co.

Lilly Endowment
Vanguard Group
BlackRock
Pnc Financial Services
State Street Corporation
Capital Research Global Investors
FMR
Geode Capital Management
Capital World Investors
Morgan Stanley
Wellington Management Company
State Farm Mutual Automobile Insurance Company
PRIMECAP Management Company
Jpmorgan Chase & Co
Capital Research and Management Company - Division 3

View all funds holding Eli Lilly & Co.